APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gastrointestinal Stromal Tumor Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Gastrointestinal Stromal Tumor Drug Market Analysis and Forecast 2026-2032

29 December 2025213 pages

Choose your research edition.

Industry ResearchGastrointestinal Stromal Tumor Drug Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Gastrointestinal Stromal Tumor Drug Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Gastrointestinal Stromal Tumor Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gastrointestinal Stromal Tumor Drug Market Outlook and Growth Opportunities 2026215 pages · $4,250 USDMarket Analysis & ForecastGlobal Gastrointestinal Stromal Tumor Drug Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

The global Gastrointestinal Stromal Tumor Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Gastrointestinal Stromal Tumor Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Gastrointestinal Stromal Tumor Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Gastrointestinal Stromal Tumor Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Gastrointestinal Stromal Tumor Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Gastrointestinal Stromal Tumor Drug include China Biopharmaceuticals, Zai Lab, CSPC Pharmaceuticals, Novartis, Mylan Pharms Inc., Kelun Pharmaceuticals, CStone Pharmaceuticals, Hansoh Pharmaceuticals and Vannsh Life Sciences, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Gastrointestinal Stromal Tumor Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Gastrointestinal Stromal Tumor Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Gastrointestinal Stromal Tumor Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Gastrointestinal Stromal Tumor Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Gastrointestinal Stromal Tumor Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Gastrointestinal Stromal Tumor Drug sales, projected growth trends, production technology, application and end-user industry.

Gastrointestinal Stromal Tumor Drug Segment by Company

China Biopharmaceuticals

Zai Lab

CSPC Pharmaceuticals

Novartis

Mylan Pharms Inc.

Kelun Pharmaceuticals

CStone Pharmaceuticals

Hansoh Pharmaceuticals

Vannsh Life Sciences

Teva Pharmaceutical Industries Ltd.

Sun Pharmaceuticals

MSN Laboratories

Glenmark Pharmaceuticals Ltd.

Drug International

Dr. Reddy's Laboratories

Deciphera Pharmaceuticals

Bulat Pharmaceutical

Beacon Pharmaceuticals

Bayer Pharmaceuticals

Apotex Inc.

Actavis Generics

Gastrointestinal Stromal Tumor Drug Segment by Type

Ripretinib

Regorafenib

Sunitinib

Imatinib

Others

Gastrointestinal Stromal Tumor Drug Segment by Application

Hospital

Clinic

Others

Gastrointestinal Stromal Tumor Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gastrointestinal Stromal Tumor Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gastrointestinal Stromal Tumor Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gastrointestinal Stromal Tumor Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Gastrointestinal Stromal Tumor Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Gastrointestinal Stromal Tumor Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gastrointestinal Stromal Tumor Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Gastrointestinal Stromal Tumor Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Ripretinib Major Manufacturers Table 3. Regorafenib Major Manufacturers Table 4. Sunitinib Major Manufacturers Table 5. Imatinib Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Gastrointestinal Stromal Tumor Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Hospital Major Manufacturers Table 9. Clinic Major Manufacturers Table 10. Others Major Manufacturers Table 11. Gastrointestinal Stromal Tumor Drug Industry Trends Table 12. Gastrointestinal Stromal Tumor Drug Industry Drivers Table 13. Gastrointestinal Stromal Tumor Drug Industry Opportunities and Challenges Table 14. Gastrointestinal Stromal Tumor Drug Industry Restraints Table 15. Global Gastrointestinal Stromal Tumor Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Gastrointestinal Stromal Tumor Drug Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Gastrointestinal Stromal Tumor Drug Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Gastrointestinal Stromal Tumor Drug Revenue Market Share by Region (2021-2026) Table 19. Global Gastrointestinal Stromal Tumor Drug Revenue Market Share by Region (2027-2032) Table 20. Global Gastrointestinal Stromal Tumor Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 21. Global Gastrointestinal Stromal Tumor Drug Sales by Region (2021-2026) & (K Units) Table 22. Global Gastrointestinal Stromal Tumor Drug Sales by Region (2027-2032) & (K Units) Table 23. Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Region (2021-2026) Table 24. Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Region (2027-2032) Table 25. Global Gastrointestinal Stromal Tumor Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Gastrointestinal Stromal Tumor Drug Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Gastrointestinal Stromal Tumor Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Manufacturers (2021-2026) Table 29. Global Gastrointestinal Stromal Tumor Drug Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 30. Global Gastrointestinal Stromal Tumor Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Gastrointestinal Stromal Tumor Drug Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Gastrointestinal Stromal Tumor Drug Manufacturers, Product Type & Application Table 33. Global Gastrointestinal Stromal Tumor Drug Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Gastrointestinal Stromal Tumor Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Gastrointestinal Stromal Tumor Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Gastrointestinal Stromal Tumor Drug Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Gastrointestinal Stromal Tumor Drug Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Gastrointestinal Stromal Tumor Drug Revenue Market Share by Type (2021-2026) Table 40. Global Gastrointestinal Stromal Tumor Drug Revenue Market Share by Type (2027-2032) Table 41. Global Gastrointestinal Stromal Tumor Drug Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 42. Global Gastrointestinal Stromal Tumor Drug Sales by Type (2021-2026) & (K Units) Table 43. Global Gastrointestinal Stromal Tumor Drug Sales by Type (2027-2032) & (K Units) Table 44. Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Type (2021-2026) Table 45. Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Type (2027-2032) Table 46. Global Gastrointestinal Stromal Tumor Drug Price by Type (2021-2026) & (US$/Unit) Table 47. Global Gastrointestinal Stromal Tumor Drug Price by Type (2027-2032) & (US$/Unit) Table 48. Global Gastrointestinal Stromal Tumor Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Gastrointestinal Stromal Tumor Drug Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Gastrointestinal Stromal Tumor Drug Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Gastrointestinal Stromal Tumor Drug Revenue Market Share by Application (2021-2026) Table 52. Global Gastrointestinal Stromal Tumor Drug Revenue Market Share by Application (2027-2032) Table 53. Global Gastrointestinal Stromal Tumor Drug Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 54. Global Gastrointestinal Stromal Tumor Drug Sales by Application (2021-2026) & (K Units) Table 55. Global Gastrointestinal Stromal Tumor Drug Sales by Application (2027-2032) & (K Units) Table 56. Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Application (2021-2026) Table 57. Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Application (2027-2032) Table 58. Global Gastrointestinal Stromal Tumor Drug Price by Application (2021-2026) & (US$/Unit) Table 59. Global Gastrointestinal Stromal Tumor Drug Price by Application (2027-2032) & (US$/Unit) Table 60. China Biopharmaceuticals Company Information Table 61. China Biopharmaceuticals Business Overview Table 62. China Biopharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 63. China Biopharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolio Table 64. China Biopharmaceuticals Recent Development Table 65. Zai Lab Company Information Table 66. Zai Lab Business Overview Table 67. Zai Lab Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Zai Lab Gastrointestinal Stromal Tumor Drug Product Portfolio Table 69. Zai Lab Recent Development Table 70. CSPC Pharmaceuticals Company Information Table 71. CSPC Pharmaceuticals Business Overview Table 72. CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolio Table 74. CSPC Pharmaceuticals Recent Development Table 75. Novartis Company Information Table 76. Novartis Business Overview Table 77. Novartis Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Novartis Gastrointestinal Stromal Tumor Drug Product Portfolio Table 79. Novartis Recent Development Table 80. Mylan Pharms Inc. Company Information Table 81. Mylan Pharms Inc. Business Overview Table 82. Mylan Pharms Inc. Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Mylan Pharms Inc. Gastrointestinal Stromal Tumor Drug Product Portfolio Table 84. Mylan Pharms Inc. Recent Development Table 85. Kelun Pharmaceuticals Company Information Table 86. Kelun Pharmaceuticals Business Overview Table 87. Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolio Table 89. Kelun Pharmaceuticals Recent Development Table 90. CStone Pharmaceuticals Company Information Table 91. CStone Pharmaceuticals Business Overview Table 92. CStone Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. CStone Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolio Table 94. CStone Pharmaceuticals Recent Development Table 95. Hansoh Pharmaceuticals Company Information Table 96. Hansoh Pharmaceuticals Business Overview Table 97. Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolio Table 99. Hansoh Pharmaceuticals Recent Development Table 100. Vannsh Life Sciences Company Information Table 101. Vannsh Life Sciences Business Overview Table 102. Vannsh Life Sciences Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Vannsh Life Sciences Gastrointestinal Stromal Tumor Drug Product Portfolio Table 104. Vannsh Life Sciences Recent Development Table 105. Teva Pharmaceutical Industries Ltd. Company Information Table 106. Teva Pharmaceutical Industries Ltd. Business Overview Table 107. Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Drug Product Portfolio Table 109. Teva Pharmaceutical Industries Ltd. Recent Development Table 110. Sun Pharmaceuticals Company Information Table 111. Sun Pharmaceuticals Business Overview Table 112. Sun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Sun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolio Table 114. Sun Pharmaceuticals Recent Development Table 115. MSN Laboratories Company Information Table 116. MSN Laboratories Business Overview Table 117. MSN Laboratories Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. MSN Laboratories Gastrointestinal Stromal Tumor Drug Product Portfolio Table 119. MSN Laboratories Recent Development Table 120. Glenmark Pharmaceuticals Ltd. Company Information Table 121. Glenmark Pharmaceuticals Ltd. Business Overview Table 122. Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Drug Product Portfolio Table 124. Glenmark Pharmaceuticals Ltd. Recent Development Table 125. Drug International Company Information Table 126. Drug International Business Overview Table 127. Drug International Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Drug International Gastrointestinal Stromal Tumor Drug Product Portfolio Table 129. Drug International Recent Development Table 130. Dr. Reddy's Laboratories Company Information Table 131. Dr. Reddy's Laboratories Business Overview Table 132. Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Drug Product Portfolio Table 134. Dr. Reddy's Laboratories Recent Development Table 135. Deciphera Pharmaceuticals Company Information Table 136. Deciphera Pharmaceuticals Business Overview Table 137. Deciphera Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 138. Deciphera Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolio Table 139. Deciphera Pharmaceuticals Recent Development Table 140. Bulat Pharmaceutical Company Information Table 141. Bulat Pharmaceutical Business Overview Table 142. Bulat Pharmaceutical Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 143. Bulat Pharmaceutical Gastrointestinal Stromal Tumor Drug Product Portfolio Table 144. Bulat Pharmaceutical Recent Development Table 145. Beacon Pharmaceuticals Company Information Table 146. Beacon Pharmaceuticals Business Overview Table 147. Beacon Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 148. Beacon Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolio Table 149. Beacon Pharmaceuticals Recent Development Table 150. Bayer Pharmaceuticals Company Information Table 151. Bayer Pharmaceuticals Business Overview Table 152. Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 153. Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolio Table 154. Bayer Pharmaceuticals Recent Development Table 155. Apotex Inc. Company Information Table 156. Apotex Inc. Business Overview Table 157. Apotex Inc. Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 158. Apotex Inc. Gastrointestinal Stromal Tumor Drug Product Portfolio Table 159. Apotex Inc. Recent Development Table 160. Actavis Generics Company Information Table 161. Actavis Generics Business Overview Table 162. Actavis Generics Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 163. Actavis Generics Gastrointestinal Stromal Tumor Drug Product Portfolio Table 164. Actavis Generics Recent Development Table 165. North America Gastrointestinal Stromal Tumor Drug Revenue by Type (2021-2026) & (US$ Million) Table 166. North America Gastrointestinal Stromal Tumor Drug Revenue by Type (2027-2032) & (US$ Million) Table 167. North America Gastrointestinal Stromal Tumor Drug Sales by Type (2021-2026) & (K Units) Table 168. North America Gastrointestinal Stromal Tumor Drug Sales by Type (2027-2032) & (K Units) Table 169. North America Gastrointestinal Stromal Tumor Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 170. North America Gastrointestinal Stromal Tumor Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 171. North America Gastrointestinal Stromal Tumor Drug Revenue by Application (2021-2026) & (US$ Million) Table 172. North America Gastrointestinal Stromal Tumor Drug Revenue by Application (2027-2032) & (US$ Million) Table 173. North America Gastrointestinal Stromal Tumor Drug Sales by Application (2021-2026) & (K Units) Table 174. North America Gastrointestinal Stromal Tumor Drug Sales by Application (2027-2032) & (K Units) Table 175. North America Gastrointestinal Stromal Tumor Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 176. North America Gastrointestinal Stromal Tumor Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 177. North America Gastrointestinal Stromal Tumor Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 178. North America Gastrointestinal Stromal Tumor Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 179. North America Gastrointestinal Stromal Tumor Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 180. North America Gastrointestinal Stromal Tumor Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 181. North America Gastrointestinal Stromal Tumor Drug Sales by Country (2021-2026) & (K Units) Table 182. North America Gastrointestinal Stromal Tumor Drug Sales by Country (2027-2032) & (K Units) Table 183. North America Gastrointestinal Stromal Tumor Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 184. North America Gastrointestinal Stromal Tumor Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 185. United States Gastrointestinal Stromal Tumor Drug Revenue (2021-2032) & (US$ Million) Table 186. Canada Gastrointestinal Stromal Tumor Drug Revenue (2021-2032) & (US$ Million) Table 187. Mexico Gastrointestinal Stromal Tumor Drug Revenue (2021-2032) & (US$ Million) Table 188. Europe Gastrointestinal Stromal Tumor Drug Revenue by Type (2021-2026) & (US$ Million) Table 189. Europe Gastrointestinal Stromal Tumor Drug Revenue by Type (2027-2032) & (US$ Million) Table 190. Europe Gastrointestinal Stromal Tumor Drug Sales by Type (2021-2026) & (K Units) Table 191. Europe Gastrointestinal Stromal Tumor Drug Sales by Type (2027-2032) & (K Units) Table 192. Europe Gastrointestinal Stromal Tumor Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 193. Europe Gastrointestinal Stromal Tumor Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 194. Europe Gastrointestinal Stromal Tumor Drug Revenue by Application (2021-2026) & (US$ Million) Table 195. Europe Gastrointestinal Stromal Tumor Drug Revenue by Application (2027-2032) & (US$ Million) Table 196. Europe Gastrointestinal Stromal Tumor Drug Sales by Application (2021-2026) & (K Units) Table 197. Europe Gastrointestinal Stromal Tumor Drug Sales by Application (2027-2032) & (K Units) Table 198. Europe Gastrointestinal Stromal Tumor Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 199. Europe Gastrointestinal Stromal Tumor Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 200. Europe Gastrointestinal Stromal Tumor Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 201. Europe Gastrointestinal Stromal Tumor Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 202. Europe Gastrointestinal Stromal Tumor Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 203. Europe Gastrointestinal Stromal Tumor Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 204. Europe Gastrointestinal Stromal Tumor Drug Sales by Country (2021-2026) & (K Units) Table 205. Europe Gastrointestinal Stromal Tumor Drug Sales by Country (2027-2032) & (K Units) Table 206. Europe Gastrointestinal Stromal Tumor Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 207. Europe Gastrointestinal Stromal Tumor Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 208. Germany Gastrointestinal Stromal Tumor Drug Revenue (2021-2032) & (US$ Million) Table 209. France Gastrointestinal Stromal Tumor Drug Revenue (2021-2032) & (US$ Million) Table 210. U.K. Gastrointestinal Stromal Tumor Drug Revenue (2021-2032) & (US$ Million) Table 211. Italy Gastrointestinal Stromal Tumor Drug Revenue (2021-2032) & (US$ Million) Table 212. Russia Gastrointestinal Stromal Tumor Drug Revenue (2021-2032) & (US$ Million) Table 213. Spain Gastrointestinal Stromal Tumor Drug Revenue (2021-2032) & (US$ Million) Table 214. Netherlands Gastrointestinal Stromal Tumor Drug Revenue (2021-2032) & (US$ Million) Table 215. Switzerland Gastrointestinal Stromal Tumor Drug Revenue (2021-2032) & (US$ Million) Table 216. Sweden Gastrointestinal Stromal Tumor Drug Revenue (2021-2032) & (US$ Million) Table 217. Poland Gastrointestinal Stromal Tumor Drug Revenue (2021-2032) & (US$ Million) Table 218. China Gastrointestinal Stromal Tumor Drug Revenue by Type (2021-2026) & (US$ Million) Table 219. China Gastrointestinal Stromal Tumor Drug Revenue by Type (2027-2032) & (US$ Million) Table 220. China Gastrointestinal Stromal Tumor Drug Sales by Type (2021-2026) & (K Units) Table 221. China Gastrointestinal Stromal Tumor Drug Sales by Type (2027-2032) & (K Units) Table 222. China Gastrointestinal Stromal Tumor Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 223. China Gastrointestinal Stromal Tumor Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 224. China Gastrointestinal Stromal Tumor Drug Revenue by Application (2021-2026) & (US$ Million) Table 225. China Gastrointestinal Stromal Tumor Drug Revenue by Application (2027-2032) & (US$ Million) Table 226. China Gastrointestinal Stromal Tumor Drug Sales by Application (2021-2026) & (K Units) Table 227. China Gastrointestinal Stromal Tumor Drug Sales by Application (2027-2032) & (K Units) Table 228. China Gastrointestinal Stromal Tumor Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 229. China Gastrointestinal Stromal Tumor Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 230. Asia Gastrointestinal Stromal Tumor Drug Revenue by Type (2021-2026) & (US$ Million) Table 231. Asia Gastrointestinal Stromal Tumor Drug Revenue by Type (2027-2032) & (US$ Million) Table 232. Asia Gastrointestinal Stromal Tumor Drug Sales by Type (2021-2026) & (K Units) Table 233. Asia Gastrointestinal Stromal Tumor Drug Sales by Type (2027-2032) & (K Units) Table 234. Asia Gastrointestinal Stromal Tumor Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 235. Asia Gastrointestinal Stromal Tumor Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 236. Asia Gastrointestinal Stromal Tumor Drug Revenue by Application (2021-2026) & (US$ Million) Table 237. Asia Gastrointestinal Stromal Tumor Drug Revenue by Application (2027-2032) & (US$ Million) Table 238. Asia Gastrointestinal Stromal Tumor Drug Sales by Application (2021-2026) & (K Units) Table 239. Asia Gastrointestinal Stromal Tumor Drug Sales by Application (2027-2032) & (K Units) Table 240. Asia Gastrointestinal Stromal Tumor Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 241. Asia Gastrointestinal Stromal Tumor Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 242. Asia Gastrointestinal Stromal Tumor Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 243. Asia Gastrointestinal Stromal Tumor Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 244. Asia Gastrointestinal Stromal Tumor Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 245. Asia Gastrointestinal Stromal Tumor Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 246. Asia Gastrointestinal Stromal Tumor Drug Sales by Country (2021-2026) & (K Units) Table 247. Asia Gastrointestinal Stromal Tumor Drug Sales by Country (2027-2032) & (K Units) Table 248. Asia Gastrointestinal Stromal Tumor Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 249. Asia Gastrointestinal Stromal Tumor Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 250. Japan Gastrointestinal Stromal Tumor Drug Revenue (2021-2032) & (US$ Million) Table 251. South Korea Gastrointestinal Stromal Tumor Drug Revenue (2021-2032) & (US$ Million) Table 252. India Gastrointestinal Stromal Tumor Drug Revenue (2021-2032) & (US$ Million) Table 253. Australia Gastrointestinal Stromal Tumor Drug Revenue (2021-2032) & (US$ Million) Table 254. Taiwan Gastrointestinal Stromal Tumor Drug Revenue (2021-2032) & (US$ Million) Table 255. Southeast Asia Gastrointestinal Stromal Tumor Drug Revenue (2021-2032) & (US$ Million) Table 256. SAMEA Gastrointestinal Stromal Tumor Drug Revenue by Type (2021-2026) & (US$ Million) Table 257. SAMEA Gastrointestinal Stromal Tumor Drug Revenue by Type (2027-2032) & (US$ Million) Table 258. SAMEA Gastrointestinal Stromal Tumor Drug Sales by Type (2021-2026) & (K Units) Table 259. SAMEA Gastrointestinal Stromal Tumor Drug Sales by Type (2027-2032) & (K Units) Table 260. SAMEA Gastrointestinal Stromal Tumor Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 261. SAMEA Gastrointestinal Stromal Tumor Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 262. SAMEA Gastrointestinal Stromal Tumor Drug Revenue by Application (2021-2026) & (US$ Million) Table 263. SAMEA Gastrointestinal Stromal Tumor Drug Revenue by Application (2027-2032) & (US$ Million) Table 264. SAMEA Gastrointestinal Stromal Tumor Drug Sales by Application (2021-2026) & (K Units) Table 265. SAMEA Gastrointestinal Stromal Tumor Drug Sales by Application (2027-2032) & (K Units) Table 266. SAMEA Gastrointestinal Stromal Tumor Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 267. SAMEA Gastrointestinal Stromal Tumor Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 268. SAMEA Gastrointestinal Stromal Tumor Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 269. SAMEA Gastrointestinal Stromal Tumor Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 270. SAMEA Gastrointestinal Stromal Tumor Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 271. SAMEA Gastrointestinal Stromal Tumor Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 272. SAMEA Gastrointestinal Stromal Tumor Drug Sales by Country (2021-2026) & (K Units) Table 273. SAMEA Gastrointestinal Stromal Tumor Drug Sales by Country (2027-2032) & (K Units) Table 274. SAMEA Gastrointestinal Stromal Tumor Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 275. SAMEA Gastrointestinal Stromal Tumor Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 276. Brazil Gastrointestinal Stromal Tumor Drug Revenue (2021-2032) & (US$ Million) Table 277. Argentina Gastrointestinal Stromal Tumor Drug Revenue (2021-2032) & (US$ Million) Table 278. Chile Gastrointestinal Stromal Tumor Drug Revenue (2021-2032) & (US$ Million) Table 279. Colombia Gastrointestinal Stromal Tumor Drug Revenue (2021-2032) & (US$ Million) Table 280. Peru Gastrointestinal Stromal Tumor Drug Revenue (2021-2032) & (US$ Million) Table 281. Saudi Arabia Gastrointestinal Stromal Tumor Drug Revenue (2021-2032) & (US$ Million) Table 282. Israel Gastrointestinal Stromal Tumor Drug Revenue (2021-2032) & (US$ Million) Table 283. UAE Gastrointestinal Stromal Tumor Drug Revenue (2021-2032) & (US$ Million) Table 284. Turkey Gastrointestinal Stromal Tumor Drug Revenue (2021-2032) & (US$ Million) Table 285. Iran Gastrointestinal Stromal Tumor Drug Revenue (2021-2032) & (US$ Million) Table 286. Egypt Gastrointestinal Stromal Tumor Drug Revenue (2021-2032) & (US$ Million) Table 287. Key Raw Materials Table 288. Raw Materials Key Suppliers Table 289. Gastrointestinal Stromal Tumor Drug Distributors List Table 290. Gastrointestinal Stromal Tumor Drug Customers List Table 291. Research Programs/Design for This Report Table 292. Authors List of This Report Table 293. Secondary Sources Table 294. Primary Sources List of Figures Figure 1. Gastrointestinal Stromal Tumor Drug Image Figure 2. Global Gastrointestinal Stromal Tumor Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gastrointestinal Stromal Tumor Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Ripretinib Image Figure 5. Regorafenib Image Figure 6. Sunitinib Image Figure 7. Imatinib Image Figure 8. Others Image Figure 9. Global Gastrointestinal Stromal Tumor Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Gastrointestinal Stromal Tumor Drug Market Size Share 2021 VS 2025 VS 2032 Figure 11. Hospital Image Figure 12. Clinic Image Figure 13. Others Image Figure 14. Global Gastrointestinal Stromal Tumor Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Gastrointestinal Stromal Tumor Drug Revenue (2021-2032) & (US$ Million) Figure 16. Global Gastrointestinal Stromal Tumor Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Gastrointestinal Stromal Tumor Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Gastrointestinal Stromal Tumor Drug Revenue Market Share by Region (2021-2032) Figure 19. Global Gastrointestinal Stromal Tumor Drug Sales (2021-2032) & (K Units) Figure 20. Global Gastrointestinal Stromal Tumor Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 21. Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Gastrointestinal Stromal Tumor Drug Sales YoY (2021-2032) & (K Units) Figure 23. Europe Gastrointestinal Stromal Tumor Drug Sales YoY (2021-2032) & (K Units) Figure 24. China Gastrointestinal Stromal Tumor Drug Sales YoY (2021-2032) & (K Units) Figure 25. Asia (Excluding China) Gastrointestinal Stromal Tumor Drug Sales YoY (2021-2032) & (K Units) Figure 26. South America, Middle East and Africa Gastrointestinal Stromal Tumor Drug Sales YoY (2021-2032) & (K Units) Figure 27. Global Gastrointestinal Stromal Tumor Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Gastrointestinal Stromal Tumor Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Gastrointestinal Stromal Tumor Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Gastrointestinal Stromal Tumor Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Gastrointestinal Stromal Tumor Drug Revenue Market Share by Type (2021-2032) Figure 33. Global Gastrointestinal Stromal Tumor Drug Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 34. Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Type (2021-2032) Figure 36. Global Gastrointestinal Stromal Tumor Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Gastrointestinal Stromal Tumor Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Gastrointestinal Stromal Tumor Drug Revenue Market Share by Application (2021-2032) Figure 39. Global Gastrointestinal Stromal Tumor Drug Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 40. Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Application (2021-2032) Figure 42. North America Gastrointestinal Stromal Tumor Drug Revenue Share by Type (2021-2032) Figure 43. North America Gastrointestinal Stromal Tumor Drug Sales Share by Type (2021-2032) Figure 44. North America Gastrointestinal Stromal Tumor Drug Revenue Share by Application (2021-2032) Figure 45. North America Gastrointestinal Stromal Tumor Drug Sales Share by Application (2021-2032) Figure 46. North America Gastrointestinal Stromal Tumor Drug Revenue Share by Country (2021-2032) Figure 47. North America Gastrointestinal Stromal Tumor Drug Sales Share by Country (2021-2032) Figure 48. Europe Gastrointestinal Stromal Tumor Drug Revenue Share by Type (2021-2032) Figure 49. Europe Gastrointestinal Stromal Tumor Drug Sales Share by Type (2021-2032) Figure 50. Europe Gastrointestinal Stromal Tumor Drug Revenue Share by Application (2021-2032) Figure 51. Europe Gastrointestinal Stromal Tumor Drug Sales Share by Application (2021-2032) Figure 52. Europe Gastrointestinal Stromal Tumor Drug Revenue Share by Country (2021-2032) Figure 53. Europe Gastrointestinal Stromal Tumor Drug Sales Share by Country (2021-2032) Figure 54. China Gastrointestinal Stromal Tumor Drug Revenue Share by Type (2021-2032) Figure 55. China Gastrointestinal Stromal Tumor Drug Sales Share by Type (2021-2032) Figure 56. China Gastrointestinal Stromal Tumor Drug Revenue Share by Application (2021-2032) Figure 57. China Gastrointestinal Stromal Tumor Drug Sales Sha

Scope & coverage.

Types
  • Ripretinib
  • Regorafenib
  • Sunitinib
  • Imatinib
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • China Biopharmaceuticals
  • Zai Lab
  • CSPC Pharmaceuticals
  • Novartis
  • Mylan Pharms Inc.
  • Kelun Pharmaceuticals
  • CStone Pharmaceuticals
  • Hansoh Pharmaceuticals
  • Vannsh Life Sciences
  • Teva Pharmaceutical Industries Ltd.
  • Sun Pharmaceuticals
  • MSN Laboratories
  • Glenmark Pharmaceuticals Ltd.
  • Drug International
  • Dr. Reddy's Laboratories
  • Deciphera Pharmaceuticals
  • Bulat Pharmaceutical
  • Beacon Pharmaceuticals
  • Bayer Pharmaceuticals
  • Apotex Inc.
  • Actavis Generics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Gastrointestinal Stromal Tumor Drug Market by Type
  3. 1.2.1 Global Gastrointestinal Stromal Tumor Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Ripretinib
  5. 1.2.3 Regorafenib
  6. 1.2.4 Sunitinib
  7. 1.2.5 Imatinib
  8. 1.2.6 Others
  9. 1.3 Gastrointestinal Stromal Tumor Drug Market by Application
  10. 1.3.1 Global Gastrointestinal Stromal Tumor Drug Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Hospital
  12. 1.3.3 Clinic
  13. 1.3.4 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Gastrointestinal Stromal Tumor Drug Market Dynamics
  1. 2.1 Gastrointestinal Stromal Tumor Drug Industry Trends
  2. 2.2 Gastrointestinal Stromal Tumor Drug Industry Drivers
  3. 2.3 Gastrointestinal Stromal Tumor Drug Industry Opportunities and Challenges
  4. 2.4 Gastrointestinal Stromal Tumor Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Gastrointestinal Stromal Tumor Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Gastrointestinal Stromal Tumor Drug Revenue by Region
  3. 3.2.1 Global Gastrointestinal Stromal Tumor Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Gastrointestinal Stromal Tumor Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Gastrointestinal Stromal Tumor Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Gastrointestinal Stromal Tumor Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Gastrointestinal Stromal Tumor Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Gastrointestinal Stromal Tumor Drug Sales by Region
  9. 3.4.1 Global Gastrointestinal Stromal Tumor Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Gastrointestinal Stromal Tumor Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Gastrointestinal Stromal Tumor Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Gastrointestinal Stromal Tumor Drug Revenue by Manufacturers
  2. 4.1.1 Global Gastrointestinal Stromal Tumor Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Gastrointestinal Stromal Tumor Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Gastrointestinal Stromal Tumor Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Gastrointestinal Stromal Tumor Drug Sales by Manufacturers
  6. 4.2.1 Global Gastrointestinal Stromal Tumor Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Gastrointestinal Stromal Tumor Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Gastrointestinal Stromal Tumor Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Gastrointestinal Stromal Tumor Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Gastrointestinal Stromal Tumor Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Gastrointestinal Stromal Tumor Drug Manufacturers, Product Type & Application
  13. 4.7 Global Gastrointestinal Stromal Tumor Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Gastrointestinal Stromal Tumor Drug Market CR5 and HHI
  16. 4.8.2 2025 Gastrointestinal Stromal Tumor Drug Tier 1, Tier 2, and Tier 3
5 Gastrointestinal Stromal Tumor Drug Market by Type
  1. 5.1 Global Gastrointestinal Stromal Tumor Drug Revenue by Type
  2. 5.1.1 Global Gastrointestinal Stromal Tumor Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Gastrointestinal Stromal Tumor Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Gastrointestinal Stromal Tumor Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Gastrointestinal Stromal Tumor Drug Sales by Type
  6. 5.2.1 Global Gastrointestinal Stromal Tumor Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Gastrointestinal Stromal Tumor Drug Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Gastrointestinal Stromal Tumor Drug Price by Type
6 Gastrointestinal Stromal Tumor Drug Market by Application
  1. 6.1 Global Gastrointestinal Stromal Tumor Drug Revenue by Application
  2. 6.1.1 Global Gastrointestinal Stromal Tumor Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Gastrointestinal Stromal Tumor Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Gastrointestinal Stromal Tumor Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Gastrointestinal Stromal Tumor Drug Sales by Application
  6. 6.2.1 Global Gastrointestinal Stromal Tumor Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Gastrointestinal Stromal Tumor Drug Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Gastrointestinal Stromal Tumor Drug Price by Application
7 Company Profiles
  1. 7.1 China Biopharmaceuticals
  2. 7.1.1 China Biopharmaceuticals Company Information
  3. 7.1.2 China Biopharmaceuticals Business Overview
  4. 7.1.3 China Biopharmaceuticals Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 China Biopharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolio
  6. 7.1.5 China Biopharmaceuticals Recent Developments
  7. 7.2 Zai Lab
  8. 7.2.1 Zai Lab Company Information
  9. 7.2.2 Zai Lab Business Overview
  10. 7.2.3 Zai Lab Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Zai Lab Gastrointestinal Stromal Tumor Drug Product Portfolio
  12. 7.2.5 Zai Lab Recent Developments
  13. 7.3 CSPC Pharmaceuticals
  14. 7.3.1 CSPC Pharmaceuticals Company Information
  15. 7.3.2 CSPC Pharmaceuticals Business Overview
  16. 7.3.3 CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolio
  18. 7.3.5 CSPC Pharmaceuticals Recent Developments
  19. 7.4 Novartis
  20. 7.4.1 Novartis Company Information
  21. 7.4.2 Novartis Business Overview
  22. 7.4.3 Novartis Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Novartis Gastrointestinal Stromal Tumor Drug Product Portfolio
  24. 7.4.5 Novartis Recent Developments
  25. 7.5 Mylan Pharms Inc.
  26. 7.5.1 Mylan Pharms Inc. Company Information
  27. 7.5.2 Mylan Pharms Inc. Business Overview
  28. 7.5.3 Mylan Pharms Inc. Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Mylan Pharms Inc. Gastrointestinal Stromal Tumor Drug Product Portfolio
  30. 7.5.5 Mylan Pharms Inc. Recent Developments
  31. 7.6 Kelun Pharmaceuticals
  32. 7.6.1 Kelun Pharmaceuticals Company Information
  33. 7.6.2 Kelun Pharmaceuticals Business Overview
  34. 7.6.3 Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolio
  36. 7.6.5 Kelun Pharmaceuticals Recent Developments
  37. 7.7 CStone Pharmaceuticals
  38. 7.7.1 CStone Pharmaceuticals Company Information
  39. 7.7.2 CStone Pharmaceuticals Business Overview
  40. 7.7.3 CStone Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 CStone Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolio
  42. 7.7.5 CStone Pharmaceuticals Recent Developments
  43. 7.8 Hansoh Pharmaceuticals
  44. 7.8.1 Hansoh Pharmaceuticals Company Information
  45. 7.8.2 Hansoh Pharmaceuticals Business Overview
  46. 7.8.3 Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolio
  48. 7.8.5 Hansoh Pharmaceuticals Recent Developments
  49. 7.9 Vannsh Life Sciences
  50. 7.9.1 Vannsh Life Sciences Company Information
  51. 7.9.2 Vannsh Life Sciences Business Overview
  52. 7.9.3 Vannsh Life Sciences Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Vannsh Life Sciences Gastrointestinal Stromal Tumor Drug Product Portfolio
  54. 7.9.5 Vannsh Life Sciences Recent Developments
  55. 7.10 Teva Pharmaceutical Industries Ltd.
  56. 7.10.1 Teva Pharmaceutical Industries Ltd. Company Information
  57. 7.10.2 Teva Pharmaceutical Industries Ltd. Business Overview
  58. 7.10.3 Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Drug Product Portfolio
  60. 7.10.5 Teva Pharmaceutical Industries Ltd. Recent Developments
  61. 7.11 Sun Pharmaceuticals
  62. 7.11.1 Sun Pharmaceuticals Company Information
  63. 7.11.2 Sun Pharmaceuticals Business Overview
  64. 7.11.3 Sun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Sun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolio
  66. 7.11.5 Sun Pharmaceuticals Recent Developments
  67. 7.12 MSN Laboratories
  68. 7.12.1 MSN Laboratories Company Information
  69. 7.12.2 MSN Laboratories Business Overview
  70. 7.12.3 MSN Laboratories Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 MSN Laboratories Gastrointestinal Stromal Tumor Drug Product Portfolio
  72. 7.12.5 MSN Laboratories Recent Developments
  73. 7.13 Glenmark Pharmaceuticals Ltd.
  74. 7.13.1 Glenmark Pharmaceuticals Ltd. Company Information
  75. 7.13.2 Glenmark Pharmaceuticals Ltd. Business Overview
  76. 7.13.3 Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Drug Product Portfolio
  78. 7.13.5 Glenmark Pharmaceuticals Ltd. Recent Developments
  79. 7.14 Drug International
  80. 7.14.1 Drug International Company Information
  81. 7.14.2 Drug International Business Overview
  82. 7.14.3 Drug International Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Drug International Gastrointestinal Stromal Tumor Drug Product Portfolio
  84. 7.14.5 Drug International Recent Developments
  85. 7.15 Dr. Reddy's Laboratories
  86. 7.15.1 Dr. Reddy's Laboratories Company Information
  87. 7.15.2 Dr. Reddy's Laboratories Business Overview
  88. 7.15.3 Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Drug Product Portfolio
  90. 7.15.5 Dr. Reddy's Laboratories Recent Developments
  91. 7.16 Deciphera Pharmaceuticals
  92. 7.16.1 Deciphera Pharmaceuticals Company Information
  93. 7.16.2 Deciphera Pharmaceuticals Business Overview
  94. 7.16.3 Deciphera Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Deciphera Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolio
  96. 7.16.5 Deciphera Pharmaceuticals Recent Developments
  97. 7.17 Bulat Pharmaceutical
  98. 7.17.1 Bulat Pharmaceutical Company Information
  99. 7.17.2 Bulat Pharmaceutical Business Overview
  100. 7.17.3 Bulat Pharmaceutical Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Bulat Pharmaceutical Gastrointestinal Stromal Tumor Drug Product Portfolio
  102. 7.17.5 Bulat Pharmaceutical Recent Developments
  103. 7.18 Beacon Pharmaceuticals
  104. 7.18.1 Beacon Pharmaceuticals Company Information
  105. 7.18.2 Beacon Pharmaceuticals Business Overview
  106. 7.18.3 Beacon Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Beacon Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolio
  108. 7.18.5 Beacon Pharmaceuticals Recent Developments
  109. 7.19 Bayer Pharmaceuticals
  110. 7.19.1 Bayer Pharmaceuticals Company Information
  111. 7.19.2 Bayer Pharmaceuticals Business Overview
  112. 7.19.3 Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Portfolio
  114. 7.19.5 Bayer Pharmaceuticals Recent Developments
  115. 7.20 Apotex Inc.
  116. 7.20.1 Apotex Inc. Company Information
  117. 7.20.2 Apotex Inc. Business Overview
  118. 7.20.3 Apotex Inc. Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Apotex Inc. Gastrointestinal Stromal Tumor Drug Product Portfolio
  120. 7.20.5 Apotex Inc. Recent Developments
  121. 7.21 Actavis Generics
  122. 7.21.1 Actavis Generics Company Information
  123. 7.21.2 Actavis Generics Business Overview
  124. 7.21.3 Actavis Generics Gastrointestinal Stromal Tumor Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 Actavis Generics Gastrointestinal Stromal Tumor Drug Product Portfolio
  126. 7.21.5 Actavis Generics Recent Developments
8 North America
  1. 8.1 North America Gastrointestinal Stromal Tumor Drug Market Size by Type
  2. 8.1.1 North America Gastrointestinal Stromal Tumor Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Gastrointestinal Stromal Tumor Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Gastrointestinal Stromal Tumor Drug Price by Type (2021-2032)
  5. 8.2 North America Gastrointestinal Stromal Tumor Drug Market Size by Application
  6. 8.2.1 North America Gastrointestinal Stromal Tumor Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Gastrointestinal Stromal Tumor Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Gastrointestinal Stromal Tumor Drug Price by Application (2021-2032)
  9. 8.3 North America Gastrointestinal Stromal Tumor Drug Market Size by Country
  10. 8.3.1 North America Gastrointestinal Stromal Tumor Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Gastrointestinal Stromal Tumor Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Gastrointestinal Stromal Tumor Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Gastrointestinal Stromal Tumor Drug Market Size by Type
  2. 9.1.1 Europe Gastrointestinal Stromal Tumor Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Gastrointestinal Stromal Tumor Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Gastrointestinal Stromal Tumor Drug Price by Type (2021-2032)
  5. 9.2 Europe Gastrointestinal Stromal Tumor Drug Market Size by Application
  6. 9.2.1 Europe Gastrointestinal Stromal Tumor Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Gastrointestinal Stromal Tumor Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Gastrointestinal Stromal Tumor Drug Price by Application (2021-2032)
  9. 9.3 Europe Gastrointestinal Stromal Tumor Drug Market Size by Country
  10. 9.3.1 Europe Gastrointestinal Stromal Tumor Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Gastrointestinal Stromal Tumor Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Gastrointestinal Stromal Tumor Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Gastrointestinal Stromal Tumor Drug Market Size by Type
  2. 10.1.1 China Gastrointestinal Stromal Tumor Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Gastrointestinal Stromal Tumor Drug Sales by Type (2021-2032)
  4. 10.1.3 China Gastrointestinal Stromal Tumor Drug Price by Type (2021-2032)
  5. 10.2 China Gastrointestinal Stromal Tumor Drug Market Size by Application
  6. 10.2.1 China Gastrointestinal Stromal Tumor Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Gastrointestinal Stromal Tumor Drug Sales by Application (2021-2032)
  8. 10.2.3 China Gastrointestinal Stromal Tumor Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Gastrointestinal Stromal Tumor Drug Market Size by Type
  2. 11.1.1 Asia Gastrointestinal Stromal Tumor Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Gastrointestinal Stromal Tumor Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Gastrointestinal Stromal Tumor Drug Price by Type (2021-2032)
  5. 11.2 Asia Gastrointestinal Stromal Tumor Drug Market Size by Application
  6. 11.2.1 Asia Gastrointestinal Stromal Tumor Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Gastrointestinal Stromal Tumor Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Gastrointestinal Stromal Tumor Drug Price by Application (2021-2032)
  9. 11.3 Asia Gastrointestinal Stromal Tumor Drug Market Size by Country
  10. 11.3.1 Asia Gastrointestinal Stromal Tumor Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Gastrointestinal Stromal Tumor Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Gastrointestinal Stromal Tumor Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Gastrointestinal Stromal Tumor Drug Market Size by Type
  2. 12.1.1 SAMEA Gastrointestinal Stromal Tumor Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Gastrointestinal Stromal Tumor Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Gastrointestinal Stromal Tumor Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Gastrointestinal Stromal Tumor Drug Market Size by Application
  6. 12.2.1 SAMEA Gastrointestinal Stromal Tumor Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Gastrointestinal Stromal Tumor Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Gastrointestinal Stromal Tumor Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Gastrointestinal Stromal Tumor Drug Market Size by Country
  10. 12.3.1 SAMEA Gastrointestinal Stromal Tumor Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Gastrointestinal Stromal Tumor Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Gastrointestinal Stromal Tumor Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Gastrointestinal Stromal Tumor Drug Value Chain Analysis
  2. 13.1.1 Gastrointestinal Stromal Tumor Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Gastrointestinal Stromal Tumor Drug Production Mode & Process
  6. 13.2 Gastrointestinal Stromal Tumor Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Gastrointestinal Stromal Tumor Drug Distributors
  9. 13.2.3 Gastrointestinal Stromal Tumor Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst